Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration.
Clinical specimens obtained from human subjects after intravenous cocaine administration were analyzed by the TDx Cocaine Metabolite Assay (TDx) and by GC/MS for benzoylecgonine. The TDx results were significantly correlated with results by GC/MS assay with no evidence of bias in the TDx assay. All cocaine metabolite positive specimens (greater than or equal to 300 ng/ml) were confirmed by GC/MS. Detection times to the last positive specimen by TDx assay and GC/MS assay of four subjects after a 20-mg intravenous dose of cocaine ranged from 29.3 to 39.1 h and 27.9 and 36.6 h, respectively. Overall, the TDx assay was found to be highly specific and accurate for the detection and measurement of benzoylecgonine in urine.
Cone
E J
EJ
National Institute on Drug Abuse, Addiction Research Center, Baltimore, MD 21224.
Menchen
S L
SL
Mitchell
J
J
D003042:Cocaine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000652:urine; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D019966:Substance-Related Disorders / Q000652:urine*; D013997:Time Factors
C005618:benzoylecgonine; D003042:Cocaine